Table 4.
Response | N | % |
---|---|---|
Stable disease | 16 | 42 |
Progression | 10 | 26 |
Unevaluable | 12 | 32 |
Complete response | 0 | 0 |
Stable disease = neither complete pathologic response nor distant metastatic progression. Progression = development of distant metastatic disease. Unevaluable = inadequate nodal staging, went off study, no pathologic data available.